title: Hepatitis and Lupus-Like Syndrome during Infliximab Therapy for Psoriasis.
abstract: Biologics are very useful medications that changed the lives of many patients in the last decade. However, we still do not know about the long-term side effects of these drugs. Infliximab is an anti-TNF chimeric antibody widely used and approved for the treatment of many diseases. Lupus-like syndrome and hepatitis are among the uncommon side effects of infliximab. Most of the written literature was published for cases of rheumatology and gastroenterology. We report here a case of both hepatitis and lupus-like syndrome that occurred sequentially in the same patient and compare our finding with two case reports of the same side effects, drug and disease.
authors.affiliation: Hamad Medical Corporation, Doha, Qatar.
authors.forename: Hassan
authors.initials: H
authors.lastname: Riad
authors.forename: Samya Abu
authors.initials: SA
authors.lastname: Shaikha
authors.forename: Hamda Al
authors.initials: HA
authors.lastname: Ansari
authors.forename: Khalifa Al
authors.initials: KA
authors.lastname: Naama
authors.forename: Hussein Al
authors.initials: HA
authors.lastname: Sada
authors.forename: Mariam Al
authors.initials: MA
authors.lastname: Mansoori
keywords: Hepatitis; Infliximab therapy; Lupus-like syndrome; Psoriasis
references.citation: Mayo Clin Proc. 2009 Nov;84(11):979-84
references.pmid: 19880688
references.citation: J Dtsch Dermatol Ges. 2012 Dec;10(12):889-97
references.pmid: 22937775
references.citation: J Cutan Med Surg. 2010 Mar-Apr;14(2):100-4
references.pmid: 20338127
references.citation: Australas J Dermatol. 2014 Feb;55(1):75-9
references.pmid: 23651182
references.citation: Br J Dermatol. 2007 Feb;156(2):329-36
references.pmid: 17223874
references.citation: Curr Opin Rheumatol. 2013 Jan;25(1):56-64
references.pmid: 23114587
references.citation: J Am Acad Dermatol. 2007 Jan;56(1):31.e1-15
references.pmid: 17097378
references.citation: Inflamm Bowel Dis. 2008 May;14(5):723-5
references.pmid: 17929297
references.citation: Clin Gastroenterol Hepatol. 2013 May;11(5):558-564.e3
references.pmid: 23333219
references.citation: J Assoc Physicians India. 2012 Sep;60:59-60
references.pmid: 23547416